NCT05789732View on ClinicalTrials.gov

Silodosin, Tadalafil Alone vs. Silodosin Plus Tadalafil as MET for Lower Ureteric Stones

NACompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

March 30, 2022

Primary Completion Date

August 30, 2022

Study Completion Date

August 30, 2022

Conditions
Lower Ureteric StonesMedical Expulsive TherapyTadalafilSilodosin
Interventions
DRUG

Placebo

Patients will receive placebo treatment once daily.

DRUG

Silodosin

Patients will receive Silodosin 8 mg once daily.

DRUG

Tadalafil

Patients will receive Tadalafil 5 mg once daily.

DRUG

Silodosin and Tadalafil

Patients will receive Silodosin 8mg in combination with Tadalafil 5 mg once daily.

Trial Locations (1)

Unknown

Benha University Hospitals, Banhā

All Listed Sponsors
lead

Benha University

OTHER